A Study on the Safety and Effectiveness of Tislelizumab Combined With Axitinib for Neoadjuvant Treatment of ccRCC
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05172440 |
|
Recruitment Status :
Active, not recruiting
First Posted : December 29, 2021
Last Update Posted : December 29, 2021
|
Sponsor:
Hongqian Guo
Information provided by (Responsible Party):
Hongqian Guo, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Estimated Primary Completion Date : | November 20, 2023 |
| Estimated Study Completion Date : | October 1, 2024 |